Comparing ERCP with and without Gall Bladder Drainage
Official title: Randomized Multicentre Double-blind Clinical Trial Comparing ERCP vs ERCP and Transmural Gall Bladder Drainage in Non-surgical Patients With Symptomatic Choledocholithiasis
Run by Hospital del Rio Hortega · NCT03921502 · Data updated 2026-11-12
This study is testing if adding gallbladder drainage to a common procedure for bile duct stones can help older patients avoid complications better than just the procedure alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Hospital del Rio Hortega Academic / other |
| Locations | 1 site (Valladolid) |
| Status | Recruiting |
| Started | August 1, 2019 |
| Main results expected | December 1, 2022 |
| Study ends | May 1, 2026 |
| Registry record updated | March 11, 2025 |
| Trial ID | NCT03921502 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients over 75 years old with symptomatic choledocholithiasis who are not eligible for surgical treatment.
✕Probably not a fit
Patients with a Charlson comorbidity score adjusted for age of less than 4 or those with other acute conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of combining endoscopic retrograde cholangiopancreatography (ERCP) with transmural gallbladder drainage in patients over 75 years old who have symptomatic choledocholithiasis and are not candidates for surgery. The study aims to determine if this combined approach reduces the incidence of biliary complications compared to ERCP alone over a one-year follow-up period. It is a multicentric, double-blind, randomized trial involving approximately 150 participants split into two groups. The trial will also assess technical success rates and complications associated with each intervention.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of recurrent biliary complications in elderly patients who cannot undergo surgery.
How similar studies have gone: While this specific combination of treatments is being tested, similar approaches in managing biliary complications have shown promise in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Symptomatic choledocholithiasis (choledocholithiasis demonstrated radiologically or highly suspected by clinical data (acute cholangitis or obstructive jaundice), analytical and imaging according to the criteria of high probability of choledocholithiasis established in the clinical guidelines (ASGE Guide). * Discarded for surgical treatment due to age, comorbidity or refusal of the patient. * Age\>75 years Exclusion Criteria: * Charlson comorbidity scale adjusted to age \<4. * Hepatobiliary surgery or previous superior digestive tract. * Ascitis. * Inability to tolerate sedation of endoscopy, perforation of the digestive tract or other contraindication to endoscopy. * Coagulopathy with INR (international normalized ratio) \> 1.5 not correctable or thrombocytopenia \<50000 / mm3 not correctable. * Other diagnoses at admission (acute cholecystitis, acute pancreatitis, biliopancreatic neoplasia). * Hemodynamic instability. * Urgent procedure performed after hours * No availability of expert material / endoscopist in drainage. * Anatomical impossibility of performing biliary drainage (absence of vesicular distension, contact between gallbladder and stomach or duodenum, contact area \<10 mm). * Baseline ECOG (Easthern Cooperative Oncology Group) \> = 4 * Expectancy of survival \<6 months. * Refusal to participate. * Distance between the gallbladder and upper digestive tract\> 1cm, scleroatrophic vesicle, lack of stable acoustic window for drainage * ERCP failed (inhability to dain common bile duct)
Where it's running
-
Hospital Rio Hortega
Valladolid, Spain Recruiting
Study contacts
- Principal investigator: Ana Y Carbajo López, MD — Hospital Río Hortega
- Study coordinator: Marina de Benito Sanz, MD
- Email: mbenitosa@saludcastillayleon.es
- Phone: 983420400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyoscine Butylbromide During Transcystic Papillary Balloon Dilation for Choledocholithiasis
This study tests whether giving hyoscine butylbromide during laparoscopic transcystic papillary balloon dilation helps patients with common bile duct stones by making the procedure faster or easier.
-
Holmium laser versus electrohydraulic lithotripsy for difficult bile duct and pancreatic duct stones
This will test whether a low-power holmium laser works and is as safe as electrohydraulic lithotripsy for adults with large or hard-to-remove bile duct or pancreatic duct stones.
-
Intraductal antibiotic given during ERCP for acute cholangitis
This trial tests whether putting an antibiotic directly into the bile ducts during ERCP, together with standard IV antibiotics, helps adults with mild-to-moderate acute cholangitis recover faster and avoid worsening infection compared with IV antibiotics alone.
-
Comparing the carbon footprint of endoscopic ultrasound versus MRCP for suspected common bile duct stones
This project will test whether endoscopic ultrasound (EUS) produces a smaller carbon footprint than MRCP when used to check for common bile duct (CBD) stones in adults with intermediate risk.
-
Early versus late laparoscopic gallbladder removal after clearing common bile duct stones with ERCP
This trial will test whether having your gallbladder removed soon after ERCP or waiting longer gives better outcomes for people who had stones cleared from their common bile duct.
-
One-stage laparoendoscopic approach for gallbladder and common bile duct stones
This trial tests whether a single-operation laparoendoscopic 'rendezvous' approach—combining laparoscopic gallbladder removal with endoscopic bile duct clearance—works safely and effectively for patients with both gallbladder and common bile duct stones.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.